Capsida Biotherapeutics Debuts with $140 Million of Capital ...Middle East

PR Newswire - News
Capsida Biotherapeutics Debuts with $140 Million of Capital
THOUSAND OAKS, Calif., April 29, 2021 /PRNewswire/ -- Versant Ventures and Westlake Village BioPartners today announced the emergence from stealth mode of Capsida Biotherapeutics Inc., a biotechnology company using an adeno-associated virus (AAV) engineering and cargo development platform...

Hence then, the article about capsida biotherapeutics debuts with 140 million of capital was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Capsida Biotherapeutics Debuts with $140 Million of Capital )

Apple Storegoogle play

Last updated :

Also on site :